tiprankstipranks
Bluejay Diagnostics (BJDX)
NASDAQ:BJDX
US Market
Holding BJDX?
Track your performance easily

Bluejay Diagnostics (BJDX) Income Statement

84 Followers

Bluejay Diagnostics Income Statement

Last quarter (Q3 2024), Bluejay Diagnostics's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Bluejay Diagnostics's net income was $-1.48M. See Bluejay Diagnostics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
--$ 249.04K-$ 0.00$ 0.00
Cost of Revenue
--$ 200.13K---
Gross Profit
--$ 48.91K---
Operating Expense
$ 3.22M$ 10.31M$ 9.37M$ 3.23M$ 1.20M$ 1.63M
Operating Income
$ -8.07M$ -10.31M$ -9.32M$ -3.23M$ -1.20M$ -1.63M
Net Non Operating Interest Income Expense
$ -16.19K$ 164.90K$ -89.67K$ -367.46K$ -27.00K$ 52.28K
Other Income Expense
$ 1.07M$ 192.43K$ -68.84K$ -109.32K$ 65.10K$ 759.29K
Pretax Income
$ -3.73M$ -9.95M$ -9.30M$ -3.49M$ -1.16M$ -819.84K
Tax Provision
$ 16.80M$ 16.80M$ 10.80M---
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -8.59M$ -9.95M$ -9.30M$ -3.49M$ -1.16M$ -819.84K
Basic EPS
$ -28.19$ -3.63K$ -9.20$ -8.20$ -0.09$ -0.06
Diluted EPS
$ -28.19$ -3.63K$ -9.20$ -8.20$ -0.09$ -0.06
Basic Average Shares
$ 3.19M$ 2.74K$ 1.01M$ 426.12K$ 12.69M$ 12.69M
Diluted Average Shares
$ 3.19M$ 2.74K$ 1.01M-$ 12.69M$ 12.69M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 3.22M$ 10.31M$ 9.57M$ 3.23M$ 1.20M$ 1.63M
Net Income From Continuing And Discontinued Operation
$ -8.59M$ -9.95M$ -9.30M$ -3.49M$ -1.16M$ -819.84K
Normalized Income
$ -5.74M$ -7.86M--$ -1.22M$ -829.68K
Interest Expense
----$ 27.00K-
EBIT
$ -3.63M$ -10.31M$ -9.32M$ -3.00M$ -1.13M$ -1.63M
EBITDA
$ -3.41M$ -9.53M$ -9.01M$ -2.62M$ -974.25K$ -1.49M
Currency in USD

Bluejay Diagnostics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis